Influence of a low dose of amphetamine on vesicular monoamine transporter binding: A PET (+)[11C]DTBZ study in humans

Synapse

Volumn 64, Issue 6, 2010, Pages 417-420

  Boileau, Isabelle ^a   Houle, Sylvain ^a   Rusjan, Pablo M ^a   Furukawa, Yoshiaki ^a   Wilkins, Diana ^b   Tong, Junchao ^a   Selby, Peter ^a   Wilson, Alan A ^a   Kish, Stephen J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Amphetamine; Dihydrotetrabenazine; Dopamine; Positron emission tomography; Vesicular monoamine transporter II

Indexed keywords

AMPHETAMINE; DIHYDROTETRABENAZINE; DOPAMINE; VESICULAR MONOAMINE TRANSPORTER 1;

ADULT; ARTICLE; BINDING AFFINITY; CORPUS STRIATUM; FEMALE; HUMAN; LOW DRUG DOSE; MALE; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADMINISTRATION, ORAL; ADULT; AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; BINDING, COMPETITIVE; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; TETRABENAZINE; VESICULAR MONOAMINE TRANSPORT PROTEINS; YOUNG ADULT;

EID: 77952938716     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20743     Document Type: Article

References (19)

1. Boileau I, Rusjan P, Houle S, Wilkins D, Tong J, Selby P, Guttman M, Saint-Cyr JA, Wilson AA, Kish SJ. 2008. Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker? J Neurosci 28:9850-9856.
2. De La Fuente-Fernandez R, Furtado S, Guttman M, Furukawa Y, Lee CS, Calne DB, Ruth TJ, Stoessl AJ. 2003. VMAT2 binding is elevated in dopa-responsive dystonia: Visualizing empty vesicles by PET. Synapse 49:20-28. (Pubitemid 36618247)
3. de la Fuente-Fernandez R, Sossi V, McCormick S, Schulzer M, Ruth TJ, Stoessl AJ. 2009. Visualizing vesicular dopamine dynamics in Parkinson's disease. Synapse 63:713-716.
4. Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR. 2007. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 47:681-698.
5. Frey KA, Koeppe RA, Kilbourn MR. 2001. Imaging the vesicular monoamine transporter. Adv Neurol 86:237-247.
6. Fuente-Fernandez R, Furtado S, Guttman M, Furukawa Y, Lee CS, Calne DB, Ruth TJ, Stoessl AJ. 2003. VMAT2 binding is elevated in dopa-responsive dystonia: Visualizing empty vesicles by PET. Synapse 49:20.
7. Haertzen CA, Hill HE, Belleville RE. 1963. Development of the addiction research center inventory (arci): Selection of items that are sensitive to the effects of various drugs. Psychopharmacologia 70:155.
8. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE. 2007. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533-1539.
9. 11C]DTBZ binding in awake rat brain. NeuroImage 41(Suppl. 2): Abstract T54.
10. Lammertsma AA, Hume SP. 1996. Simplified reference tissue model for PET receptor studies. Neuroimage 4(3,Part 1):153.
11. Laruelle M. 2000. Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review. J Cereb Blood Flow Metab 20:423.
12. Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y, Cooper T, Kegeles L, Zarahn E, Abi-Dargham A, Haber SN, Laruelle M. 2003. Imaging human mesolimbic dopamine transmission with positron emission tomography. II. Amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 23:285.
13. Partilla JS, Dempsey AG, Nagpal AS, Blough BE, Baumann MH, Rothman RB. 2006. Interaction of amphetamines and related compounds at the vesicular monoamine transporter. J Pharmacol Exp Ther 319:237-246.
14. Scherman D, Raisman R, Ploska A, Agid Y. 1988. [3H]dihydrotetrabenazine, a new in vitro monoaminergic probe for human brain. J Neurochem 50:1131-1136.
15. Seiden LS, Sabol KE, Ricaurte GA. 1993. Amphetamine: Effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 33:639-677.
16. Sulzer D, Sonders MS, Poulsen NW, Galli A. 2005. Mechanisms of neurotransmitter release by amphetamines: A review. Prog Neurobiol 75:406. (Pubitemid 40834286)
17. 11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration. Synapse 62:873-876.
18. 11C]-(1)-PHNO positron emission tomography study. Neuropsychopharmacology 33:279-289.
19. 11C]-iodomethane: A remarkably simple captive solvent method. Nucl Med Biol 27:529-532.